Where to go with new expensive treatments in NSCLC
Open Access
- 1 July 1998
- journal article
- editorial
- Published by Springer Nature in British Journal of Cancer
- Vol. 78 (2) , 159-162
- https://doi.org/10.1038/bjc.1998.458
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Dose-finding study of irinotecan and cisplatin plus concurrent radiotherapy for unresectable stage III non-small-cell lung cancerBritish Journal of Cancer, 1998
- A phase II trial of combination of CPT-11 and cisplatin for advanced non-small-cell lung cancerBritish Journal of Cancer, 1998
- Tamoxifen and Chemotherapy for Lymph Node-Negative, Estrogen Receptor-Positive Breast CancerJNCI Journal of the National Cancer Institute, 1997
- Defining the role of paclitaxel in lung cancer: summary of recent studies and implications for future directions.1997
- Regulating the pharmaceutical industryBMJ, 1997
- A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung CancerNew England Journal of Medicine, 1994
- Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: a phase III study of the Southwest Oncology Group.Journal of Clinical Oncology, 1993
- A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer.Journal of Clinical Oncology, 1992
- A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma.Journal of Clinical Oncology, 1986
- Cisplatin and Vindesine Combination Chemotherapy for Advanced Carcinoma of the Lung: A Randomized Trial Investigating Two Dosage SchedulesAnnals of Internal Medicine, 1981